Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain.
Identifieur interne : 000039 ( Main/Exploration ); précédent : 000038; suivant : 000040Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain.
Auteurs : Noelia Rodríguez-Blanco [Espagne] ; José Tuells [Espagne] ; Rafael Vila-Candel [Espagne] ; Andreu Nolasco [Espagne]Source :
- International journal of environmental research and public health [ 1660-4601 ] ; 2019.
Descripteurs français
- KwdFr :
- Adulte (MeSH), Complications infectieuses de la grossesse (prévention et contrôle), Coqueluche (prévention et contrôle), Couverture vaccinale (statistiques et données numériques), Enregistrements (MeSH), Espagne (MeSH), Femelle (MeSH), Femmes enceintes (MeSH), Grippe humaine (prévention et contrôle), Grossesse (MeSH), Humains (MeSH), Programmes de vaccination (MeSH), Vaccin anticoquelucheux (usage thérapeutique), Vaccins antigrippaux (usage thérapeutique), Études prospectives (MeSH).
- MESH :
- prévention et contrôle : Complications infectieuses de la grossesse, Coqueluche, Grippe humaine.
- statistiques et données numériques : Couverture vaccinale.
- usage thérapeutique : Vaccin anticoquelucheux, Vaccins antigrippaux.
- Adulte, Enregistrements, Espagne, Femelle, Femmes enceintes, Grossesse, Humains, Programmes de vaccination, Études prospectives.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Adult (MeSH), Female (MeSH), Humans (MeSH), Immunization Programs (MeSH), Influenza Vaccines (therapeutic use), Influenza, Human (prevention & control), Pertussis Vaccine (therapeutic use), Pregnancy (MeSH), Pregnancy Complications, Infectious (prevention & control), Pregnant Women (MeSH), Prospective Studies (MeSH), Registries (MeSH), Spain (MeSH), Vaccination Coverage (statistics & numerical data), Whooping Cough (prevention & control).
- MESH :
- chemical , therapeutic use : Influenza Vaccines, Pertussis Vaccine.
- geographic : Spain.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious, Whooping Cough.
- statistics & numerical data : Vaccination Coverage.
- Adult, Female, Humans, Immunization Programs, Pregnancy, Pregnant Women, Prospective Studies, Registries.
Abstract
Background: Pregnant women should receive two vaccines during pregnancy due to maternal-foetal complications and risks as well as the influenza and pertussis vaccinations. The goal was to evaluate vaccination coverage against influenza and pertussis in pregnant women, following midwife professional advice during the pregnancy follow-up; Methods: Prospective cohort study of 1017 pregnancies during the vaccination campaign in 2015⁻2016. To estimate the degree of consistency between the coverage declared by mothers and that registered in the Nominal Vaccination Registry (NVR), we used the Cohen's kappa index (k); Results: 95.4% were registered in the NVR. Vaccination coverage recorded against influenza was 64.2% (95% CI: 61.2⁻67.2), and 89.8% (95% CI: 87.9⁻91.7) against pertussis. The coverage of the pregnant women interviewed was 61.7% (95% CI: 58.1⁻67.3)) for influenza and 92.3% (95% CI: 91.4⁻95.3) for pertussis. Subsequent interviews of 67.2% of the women produced a kappa agreement index between the data obtained from interviews and those recorded in the NVR of 0.974 (IC95%: 98.0⁻99.6) for influenza, and 0.921 (IC95%: 98.1⁻99.7) for pertussis. The women identified midwives as the main source of vaccination information and advice 88.4% (IC95%: 85.8⁻90.9); Conclusions: The NVR is an effective platform for estimating immunisation coverage in pregnant women. The degree of agreement between declared vaccinations and registered vaccinations was high for both vaccines.
DOI: 10.3390/ijerph16040543
PubMed: 30769767
PubMed Central: PMC6406959
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain.</title><author><name sortKey="Rodriguez Blanco, Noelia" sort="Rodriguez Blanco, Noelia" uniqKey="Rodriguez Blanco N" first="Noelia" last="Rodríguez-Blanco">Noelia Rodríguez-Blanco</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics and Gynaecology, Hospital Universitario del Vinalopó, Spain C/Tonico Sansano Mora, 14, 03293 Elche, Spain. nrodriguez@vinaloposalud.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Obstetrics and Gynaecology, Hospital Universitario del Vinalopó, Spain C/Tonico Sansano Mora, 14, 03293 Elche</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Department of Nursing Universidad CEU Cardenal Herrera, Plaza Reyes Católicos, 19, 03204 Elche, Spain. nrodriguez@vinaloposalud.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Nursing Universidad CEU Cardenal Herrera, Plaza Reyes Católicos, 19, 03204 Elche</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author><author><name sortKey="Tuells, Jose" sort="Tuells, Jose" uniqKey="Tuells J" first="José" last="Tuells">José Tuells</name><affiliation wicri:level="2"><nlm:affiliation>Cátedra Balmis Vacunología, University of Alicante, Campus de San Vicente Raspeig, Ap.99, E-03080 Alicante, Spain. tuells@ua.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Cátedra Balmis Vacunología, University of Alicante, Campus de San Vicente Raspeig, Ap.99, E-03080 Alicante</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author><author><name sortKey="Vila Candel, Rafael" sort="Vila Candel, Rafael" uniqKey="Vila Candel R" first="Rafael" last="Vila-Candel">Rafael Vila-Candel</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, FISABIO, Spain, Crta. Corbera km 1, 46600 Valencia, Spain. vila_rafcan@gva.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, FISABIO, Spain, Crta. Corbera km 1, 46600 Valencia</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author><author><name sortKey="Nolasco, Andreu" sort="Nolasco, Andreu" uniqKey="Nolasco A" first="Andreu" last="Nolasco">Andreu Nolasco</name><affiliation wicri:level="2"><nlm:affiliation>Unidad Mixta de Investigación para el Análisis de las Desigualdades en Salud y la Mortalidad FISABIO-UA, Departament of Community Health, Preventive Medicine and Public Health, and Science's History, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain. nolasco@ua.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad Mixta de Investigación para el Análisis de las Desigualdades en Salud y la Mortalidad FISABIO-UA, Departament of Community Health, Preventive Medicine and Public Health, and Science's History, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2019">2019</date><idno type="RBID">pubmed:30769767</idno><idno type="pmid">30769767</idno><idno type="doi">10.3390/ijerph16040543</idno><idno type="pmc">PMC6406959</idno><idno type="wicri:Area/Main/Corpus">00024</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">00024</idno><idno type="wicri:Area/Main/Curation">000024</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000024</idno><idno type="wicri:Area/Main/Exploration">000024</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain.</title><author><name sortKey="Rodriguez Blanco, Noelia" sort="Rodriguez Blanco, Noelia" uniqKey="Rodriguez Blanco N" first="Noelia" last="Rodríguez-Blanco">Noelia Rodríguez-Blanco</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics and Gynaecology, Hospital Universitario del Vinalopó, Spain C/Tonico Sansano Mora, 14, 03293 Elche, Spain. nrodriguez@vinaloposalud.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Obstetrics and Gynaecology, Hospital Universitario del Vinalopó, Spain C/Tonico Sansano Mora, 14, 03293 Elche</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation><affiliation wicri:level="2"><nlm:affiliation>Department of Nursing Universidad CEU Cardenal Herrera, Plaza Reyes Católicos, 19, 03204 Elche, Spain. nrodriguez@vinaloposalud.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Nursing Universidad CEU Cardenal Herrera, Plaza Reyes Católicos, 19, 03204 Elche</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author><author><name sortKey="Tuells, Jose" sort="Tuells, Jose" uniqKey="Tuells J" first="José" last="Tuells">José Tuells</name><affiliation wicri:level="2"><nlm:affiliation>Cátedra Balmis Vacunología, University of Alicante, Campus de San Vicente Raspeig, Ap.99, E-03080 Alicante, Spain. tuells@ua.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Cátedra Balmis Vacunología, University of Alicante, Campus de San Vicente Raspeig, Ap.99, E-03080 Alicante</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author><author><name sortKey="Vila Candel, Rafael" sort="Vila Candel, Rafael" uniqKey="Vila Candel R" first="Rafael" last="Vila-Candel">Rafael Vila-Candel</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, FISABIO, Spain, Crta. Corbera km 1, 46600 Valencia, Spain. vila_rafcan@gva.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, FISABIO, Spain, Crta. Corbera km 1, 46600 Valencia</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author><author><name sortKey="Nolasco, Andreu" sort="Nolasco, Andreu" uniqKey="Nolasco A" first="Andreu" last="Nolasco">Andreu Nolasco</name><affiliation wicri:level="2"><nlm:affiliation>Unidad Mixta de Investigación para el Análisis de las Desigualdades en Salud y la Mortalidad FISABIO-UA, Departament of Community Health, Preventive Medicine and Public Health, and Science's History, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain. nolasco@ua.es.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Unidad Mixta de Investigación para el Análisis de las Desigualdades en Salud y la Mortalidad FISABIO-UA, Departament of Community Health, Preventive Medicine and Public Health, and Science's History, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante</wicri:regionArea><placeName><region nuts="2" type="communauté">Communauté valencienne</region></placeName></affiliation></author></analytic><series><title level="j">International journal of environmental research and public health</title><idno type="eISSN">1660-4601</idno><imprint><date when="2019" type="published">2019</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term><term>Female (MeSH)</term><term>Humans (MeSH)</term><term>Immunization Programs (MeSH)</term><term>Influenza Vaccines (therapeutic use)</term><term>Influenza, Human (prevention & control)</term><term>Pertussis Vaccine (therapeutic use)</term><term>Pregnancy (MeSH)</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnant Women (MeSH)</term><term>Prospective Studies (MeSH)</term><term>Registries (MeSH)</term><term>Spain (MeSH)</term><term>Vaccination Coverage (statistics & numerical data)</term><term>Whooping Cough (prevention & control)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte (MeSH)</term><term>Complications infectieuses de la grossesse (prévention et contrôle)</term><term>Coqueluche (prévention et contrôle)</term><term>Couverture vaccinale (statistiques et données numériques)</term><term>Enregistrements (MeSH)</term><term>Espagne (MeSH)</term><term>Femelle (MeSH)</term><term>Femmes enceintes (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Grossesse (MeSH)</term><term>Humains (MeSH)</term><term>Programmes de vaccination (MeSH)</term><term>Vaccin anticoquelucheux (usage thérapeutique)</term><term>Vaccins antigrippaux (usage thérapeutique)</term><term>Études prospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Influenza Vaccines</term><term>Pertussis Vaccine</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term><term>Whooping Cough</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Complications infectieuses de la grossesse</term><term>Coqueluche</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Vaccination Coverage</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Couverture vaccinale</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Vaccin anticoquelucheux</term><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Immunization Programs</term><term>Pregnancy</term><term>Pregnant Women</term><term>Prospective Studies</term><term>Registries</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Enregistrements</term><term>Espagne</term><term>Femelle</term><term>Femmes enceintes</term><term>Grossesse</term><term>Humains</term><term>Programmes de vaccination</term><term>Études prospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><i>Background</i>: Pregnant women should receive two vaccines during pregnancy due to maternal-foetal complications and risks as well as the influenza and pertussis vaccinations. The goal was to evaluate vaccination coverage against influenza and pertussis in pregnant women, following midwife professional advice during the pregnancy follow-up; <i>Methods</i>: Prospective cohort study of 1017 pregnancies during the vaccination campaign in 2015⁻2016. To estimate the degree of consistency between the coverage declared by mothers and that registered in the Nominal Vaccination Registry (NVR), we used the Cohen's kappa index (k); <i>Results</i>: 95.4% were registered in the NVR. Vaccination coverage recorded against influenza was 64.2% (95% CI: 61.2⁻67.2), and 89.8% (95% CI: 87.9⁻91.7) against pertussis. The coverage of the pregnant women interviewed was 61.7% (95% CI: 58.1⁻67.3)) for influenza and 92.3% (95% CI: 91.4⁻95.3) for pertussis. Subsequent interviews of 67.2% of the women produced a kappa agreement index between the data obtained from interviews and those recorded in the NVR of 0.974 (IC95%: 98.0⁻99.6) for influenza, and 0.921 (IC95%: 98.1⁻99.7) for pertussis. The women identified midwives as the main source of vaccination information and advice 88.4% (IC95%: 85.8⁻90.9); <i>Conclusions</i>: The NVR is an effective platform for estimating immunisation coverage in pregnant women. The degree of agreement between declared vaccinations and registered vaccinations was high for both vaccines.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">30769767</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>4</Issue><PubDate><Year>2019</Year><Month>02</Month><Day>14</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">E543</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph16040543</ELocationID><Abstract><AbstractText><i>Background</i>: Pregnant women should receive two vaccines during pregnancy due to maternal-foetal complications and risks as well as the influenza and pertussis vaccinations. The goal was to evaluate vaccination coverage against influenza and pertussis in pregnant women, following midwife professional advice during the pregnancy follow-up; <i>Methods</i>: Prospective cohort study of 1017 pregnancies during the vaccination campaign in 2015⁻2016. To estimate the degree of consistency between the coverage declared by mothers and that registered in the Nominal Vaccination Registry (NVR), we used the Cohen's kappa index (k); <i>Results</i>: 95.4% were registered in the NVR. Vaccination coverage recorded against influenza was 64.2% (95% CI: 61.2⁻67.2), and 89.8% (95% CI: 87.9⁻91.7) against pertussis. The coverage of the pregnant women interviewed was 61.7% (95% CI: 58.1⁻67.3)) for influenza and 92.3% (95% CI: 91.4⁻95.3) for pertussis. Subsequent interviews of 67.2% of the women produced a kappa agreement index between the data obtained from interviews and those recorded in the NVR of 0.974 (IC95%: 98.0⁻99.6) for influenza, and 0.921 (IC95%: 98.1⁻99.7) for pertussis. The women identified midwives as the main source of vaccination information and advice 88.4% (IC95%: 85.8⁻90.9); <i>Conclusions</i>: The NVR is an effective platform for estimating immunisation coverage in pregnant women. The degree of agreement between declared vaccinations and registered vaccinations was high for both vaccines.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rodríguez-Blanco</LastName><ForeName>Noelia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8815-5055</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Hospital Universitario del Vinalopó, Spain C/Tonico Sansano Mora, 14, 03293 Elche, Spain. nrodriguez@vinaloposalud.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing Universidad CEU Cardenal Herrera, Plaza Reyes Católicos, 19, 03204 Elche, Spain. nrodriguez@vinaloposalud.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tuells</LastName><ForeName>José</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1159-429X</Identifier><AffiliationInfo><Affiliation>Cátedra Balmis Vacunología, University of Alicante, Campus de San Vicente Raspeig, Ap.99, E-03080 Alicante, Spain. tuells@ua.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vila-Candel</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-3734-2480</Identifier><AffiliationInfo><Affiliation>Department of Obstetrics and Gynaecology, Hospital Universitario de la Ribera, FISABIO, Spain, Crta. Corbera km 1, 46600 Valencia, Spain. vila_rafcan@gva.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nolasco</LastName><ForeName>Andreu</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6583-379X</Identifier><AffiliationInfo><Affiliation>Unidad Mixta de Investigación para el Análisis de las Desigualdades en Salud y la Mortalidad FISABIO-UA, Departament of Community Health, Preventive Medicine and Public Health, and Science's History, University of Alicante, Carretera de San Vicente del Raspeig s/n, 03690 Alicante, Spain. nolasco@ua.es.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>02</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010567">Pertussis Vaccine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010567" MajorTopicYN="N">Pertussis Vaccine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037841" MajorTopicYN="Y">Pregnant Women</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073887" MajorTopicYN="N">Vaccination Coverage</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014917" MajorTopicYN="N">Whooping Cough</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">immunisation</Keyword><Keyword MajorTopicYN="Y">influenza</Keyword><Keyword MajorTopicYN="Y">midwife</Keyword><Keyword MajorTopicYN="Y">nominal records</Keyword><Keyword MajorTopicYN="Y">pertussis vaccine</Keyword><Keyword MajorTopicYN="Y">pregnancy</Keyword><Keyword MajorTopicYN="Y">vaccine coverage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>01</Month><Day>08</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>01</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>02</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30769767</ArticleId><ArticleId IdType="pii">ijerph16040543</ArticleId><ArticleId IdType="doi">10.3390/ijerph16040543</ArticleId><ArticleId IdType="pmc">PMC6406959</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMJ Open. 2017 Oct 11;7(10):e018594</Citation><ArticleIdList><ArticleId IdType="pubmed">29025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 May 30;32(26):3122-7</Citation><ArticleIdList><ArticleId IdType="pubmed">24742490</ArticleId></ArticleIdList></Reference><Reference><Citation>Prev Med. 2017 Jun;99:111-117</Citation><ArticleIdList><ArticleId IdType="pubmed">28216380</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 Apr 19;17(16):</Citation><ArticleIdList><ArticleId IdType="pubmed">22551464</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Obstet Gynaecol. 2012 Aug;52(4):334-41</Citation><ArticleIdList><ArticleId IdType="pubmed">22486173</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Apr 18;6(4):e010911</Citation><ArticleIdList><ArticleId IdType="pubmed">27091823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2008 Jan;8(1):44-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18156088</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstet Gynecol. 2015 Nov;126(5):1069-74</Citation><ArticleIdList><ArticleId IdType="pubmed">26444109</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Nurs Stud. 2010 Apr;47(4):500-12</Citation><ArticleIdList><ArticleId IdType="pubmed">20031126</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Oct 9;359(15):1555-64</Citation><ArticleIdList><ArticleId IdType="pubmed">18799552</ArticleId></ArticleIdList></Reference><Reference><Citation>Obstet Gynecol Clin North Am. 2014 Dec;41(4):521-34</Citation><ArticleIdList><ArticleId IdType="pubmed">25454988</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Clin (Barc). 2010 Feb 13;134(4):146-51</Citation><ArticleIdList><ArticleId IdType="pubmed">19942237</ArticleId></ArticleIdList></Reference><Reference><Citation>Qual Health Res. 2015 Mar;25(3):360-70</Citation><ArticleIdList><ArticleId IdType="pubmed">25246330</ArticleId></ArticleIdList></Reference><Reference><Citation>Gac Sanit. 2016 Nov;30 Suppl 1:31-37</Citation><ArticleIdList><ArticleId IdType="pubmed">27837794</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2018 Jul 6;8(7):e022132</Citation><ArticleIdList><ArticleId IdType="pubmed">29982220</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S33-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22920057</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2015 Feb 25;15:92</Citation><ArticleIdList><ArticleId IdType="pubmed">25872565</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2015 Apr 27;33(18):2125-31</Citation><ArticleIdList><ArticleId IdType="pubmed">25796339</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust N Z J Public Health. 2008 Jun;32(3):224-9</Citation><ArticleIdList><ArticleId IdType="pubmed">18578819</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2016 Jan 2;34(1):142-50</Citation><ArticleIdList><ArticleId IdType="pubmed">26592142</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2005 Apr;192(4):1098-106</Citation><ArticleIdList><ArticleId IdType="pubmed">15846187</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Aug 15;59(4):560-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24799324</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2017 Jan 20;66(2):56-59</Citation><ArticleIdList><ArticleId IdType="pubmed">28103212</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2017 Oct 15;65(8):1289-1297</Citation><ArticleIdList><ArticleId IdType="pubmed">28525597</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2011 Jul;205(1):10-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21345415</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 2014 Aug 6;32(36):4602-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24996123</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Prev Med. 2016 Apr;50(4):480-488</Citation><ArticleIdList><ArticleId IdType="pubmed">26526159</ArticleId></ArticleIdList></Reference><Reference><Citation>J Prev Med Hyg. 2016;57(1):E13-8</Citation><ArticleIdList><ArticleId IdType="pubmed">27346934</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Perinatol. 2016 Sep;33(11):1104-14</Citation><ArticleIdList><ArticleId IdType="pubmed">27603545</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Esp Quimioter. 2018 Aug;31(4):344-352</Citation><ArticleIdList><ArticleId IdType="pubmed">29932315</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Public Health. 2016 Nov 21;16(1):1173</Citation><ArticleIdList><ArticleId IdType="pubmed">27871262</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Fam Pract. 2014 May 23;15:102</Citation><ArticleIdList><ArticleId IdType="pubmed">24884996</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Obstet Gynecol. 2012 Sep;207(3 Suppl):S67-74</Citation><ArticleIdList><ArticleId IdType="pubmed">22920063</ArticleId></ArticleIdList></Reference><Reference><Citation>Euro Surveill. 2012 Apr 26;17(17):</Citation><ArticleIdList><ArticleId IdType="pubmed">22551495</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):1000-5</Citation><ArticleIdList><ArticleId IdType="pubmed">26390253</ArticleId></ArticleIdList></Reference><Reference><Citation>Women Birth. 2016 Oct;29(5):423-429</Citation><ArticleIdList><ArticleId IdType="pubmed">26879102</ArticleId></ArticleIdList></Reference><Reference><Citation>Enferm Infecc Microbiol Clin. 2017 Nov;35(9):550-555</Citation><ArticleIdList><ArticleId IdType="pubmed">27769682</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2015 Mar 1;60(5):e11-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25409473</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2016 Dec 1;63(suppl 4):S236-S243</Citation><ArticleIdList><ArticleId IdType="pubmed">27838678</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté valencienne</li></region></list><tree><country name="Espagne"><region name="Communauté valencienne"><name sortKey="Rodriguez Blanco, Noelia" sort="Rodriguez Blanco, Noelia" uniqKey="Rodriguez Blanco N" first="Noelia" last="Rodríguez-Blanco">Noelia Rodríguez-Blanco</name></region><name sortKey="Nolasco, Andreu" sort="Nolasco, Andreu" uniqKey="Nolasco A" first="Andreu" last="Nolasco">Andreu Nolasco</name><name sortKey="Rodriguez Blanco, Noelia" sort="Rodriguez Blanco, Noelia" uniqKey="Rodriguez Blanco N" first="Noelia" last="Rodríguez-Blanco">Noelia Rodríguez-Blanco</name><name sortKey="Tuells, Jose" sort="Tuells, Jose" uniqKey="Tuells J" first="José" last="Tuells">José Tuells</name><name sortKey="Vila Candel, Rafael" sort="Vila Candel, Rafael" uniqKey="Vila Candel R" first="Rafael" last="Vila-Candel">Rafael Vila-Candel</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeEspagneV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000039 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000039 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeEspagneV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:30769767
|texte= Adherence and Concordance of Influenza and Pertussis Vaccination Coverage in Pregnant Women in Spain.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:30769767" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeEspagneV1
| This area was generated with Dilib version V0.6.37. |  |